Pathway to Progress


The Cancer Research UK Pledge Pathway to Progress garden has timber Progress-Stakes dotted amongst the plants marking key achievements from our history of life-saving research and campaigning.

It's interlocking curved design demonstrates the link between our legacy supporters and researchers.  

Together with our supporters we’ve played a role in developing 8 of the world’s top 10 cancer drugs; we’ve helped prove the link between tobacco and cancer, preventing millions of deaths worldwide; helped prove the value of cervical screening which now prevents 1000s of deaths every year; over the last 40 years our work has helped double breast cancer survival; and we were a key player in the development of radiotherapy, which now benefits more than 130,000 patients every year in the UK.

The key achievements that you'll see in the garden include:

Story begins…

The Cancer Research UK story begins...


Our research plays a part in introducing a new era of cancer treatment - chemotherapy


Cervical screening

​Our researchers carry out some of the earliest studies into cervical screening


EB Virus

Our scientists discover the first human cancer virus, Epstein Barr


1 in 4 survive

1 in 4 survive their cancer for 10 years or more in the UK


Our scientists lay the foundations for the drug temozolomide, which is used worldwide today to treat the most common type of brain tumour, glioblastoma

BRCA genes

We lead an international group of researchers who are the first to pinpoint how breast cancer risk can be inherited through the BRCA1 and BRCA2 genes

PARP inhibitors

Our researchers create the first in a new family of drugs called PARP inhibitors which exploit specific genetic weaknesses in cancer cells

2 in 4 survive

2 in 4 survive their cancer for 10 years or more in the UK

3 in 4 survive?

Our aim is for 3 in 4 to survive their cancer for 10 years or more in the UK by 2034